21 January 2019

Contents

Editorial

• 21 January 2019: vol 20 no 1: Brexit and other complications…

Treatment access

• BMJ survey reports lack of NHS planning for Brexit: impact on drug supplies unknown

• BASHH, BHIVA, HIVPA and NHIVNA statement on a no-deal Brexit

• UK-CAB statement on Brexit, HIV and access to medicines

• Model predicts benefit of dolutegravir for all in sub-Saharan Africa outweighs risk

Guidelines

• US adult HIV guidelines updated (Oct 2018)

Side effects

• Are integrase inhibitors linked to weight gain? – an evidence review

• Frailty in older HIV positive people: independent associations with serious morbidity and mortality

HIV prevention and transmission

• NHS England doubles places on IMPACT PrEP study to 26,000

• US CDC updates HIV rates in transgender people

• UK annual HIV surveillance data published – full reports

• Michigan State updates HIV disclosure laws to reflect impact of effective ART

Ageing and life expectancy

• HIV is associated with higher biological age compared to chronological age

Other news

• Activists announce alternative 2020 conference in Mexico City

On the web

• Conference abstracts online

• Chemsex: online resources

• TAGline: Intellectual Property and Access

• Influencing and monitoring PEPFAR country programmes

PDFs

• 21 January 2019 vol 20 no 1